Что скрывают противозачаточные. Как вернуть контроль над своими гормонами за 30 дней Брайтен Джолин

Приложения

Ответы на тест «Разрушение мифов о менструальном цикле»

1. Ложь

2. Ложь

3. Ложь

4. Правда

5. Ложь

6. Ложь

7. Ложь

8. Ложь

9. Правда

10. Ложь

Ваш пятый основной физиологический показатель

Список литературы

Akinloye, O., et al. “Effects of Contraceptives on Serum Trace Elements, Calcium, and Phosphorus Levels”. West Indian Medical Journal 60, no. 3 (2011): 308–15.

Aminzadeh, A., et al. “Frequency of Candidiasis and Colonization of Candida Albicans in Relation to Oral Contraceptive Pills”. Iran Red Crescent Medical Journal 18, no. 10 (2016): e38909.

Anderson, K. E., et al. “Effects of Oral Contraceptives on Vitamin Metabolism”. Advances in Clinical Chemistry 18 (1976): 247–87.

Bird, S. T., et al. “Irritable Bowel Syndrome and Drospirenone-Containing Oral Contraceptives; A Comparative-Safety Study”. Current Drug Safety 7, no. 1 (2012): 8–15.

Centers for Disease Control, Cancer and Steroid Hormone Study. “Long-Term Oral Contraceptive Use and the Risk of Breast Cancer”. JAMA 249, no. 12 (1983): 1591–95.

Chasan-Taber, L., et al. “Epidemiology of Oral-Contraceptives and Cardiovascular Disease”. Annals of Internal Medicine 128, no. 6 (1998): 467–77.

Davidson, N. E., et al. “Good News About Oral Contraceptives”. New England Journal of Medicine 346 (2002): 2078–79.

Davis, A. R., et al. “Occurrence of Menses or Pregnancy After Cessation of a Continuous Oral Contraceptive”. Fertility and Sterility 89, no. 5 (2008): 1059–63.

Dreon, D. M., et al. “Oral Contraceptive Use and Increased Plasma Concentration of C-Reactive Protein”. Life Sciences 73, no. 10 (2003): 1245–52.

Dunn, N., et al. “Oral Contraceptives and Myocardial Infarction: Results of the MICA Case Control Study”. British Medical Journal 318, no. 7198 (1999): 1579–84.

Frhlich, M., et al. “Oral Contraceptive Use Is Associated with a Systemic Acute Phase Response”. Fibrinolysis and Proteolysis 13, no. 6 (1999): 239–44.

Gingnell, M., et al. “Oral Contraceptive Use Changes Brain Activity and Mood in Women with Previous Negative Affect on the Pill – A Double-Blinded, Placebo-Controlled Randomized Trial of a Levonorgestrel-Containing Combined Oral Contraceptive”. Psychoneuroendocrinology 38, no. 7 (2013): 1133–44.

Hankinson, S. E., et al. “A Prospective Study of Oral Contraceptive Use and Risk of Breast Cancer (Nurses’ Health Study, United States)”. Cancer Causes and Control 8, no. 1 (1997): 65–72.

Hertel, J., et al. “Evidence for Stress-Like Alterations in the HPA-Axis in Women Taking Oral Contraceptives”. Scientific Reports 7, no. 1 (2017): 14111.

Hickman, R. J., et al. “C-Reactive Protein Is Elevated in Atypical but Not Nonatypical Depression: Data from the National Health and Nutrition Examination Survey (NHANES) 1999–2004”. Journal of Behavioral Medicine 37, no. 4 (2014): 621–29.

Hock, H. “The Pill and the College Attainment of American Women and Men”. Florida State University, September 15, 2005. http://paa2006.princeton.edu/papers/61745.

Jenkins, T. A., et al. “Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis”. Nutrients 8, no. 1 (2016): 56.

Khalili, H., et al. “Oral Contraceptives, Reproductive Factors, and Risk of Inflammatory Bowel Disease”. Gut 62, no. 8 (2013): 1153–59.

Khier, L. A. M. “Effects of Oral Contraceptives on the Thyroid Function in Sudanese Females”. BS thesis, University of Khartoum, 2000. https://core.ac.uk/download /pdf/71669046.pdf.Kluf, C., et al. “Pro-Inflammatory Effects of Oestrogens During Use of Oral Contraceptives and Hormone Replacement Treatment”. Vascular Pharmacology 39, no. 3 (2002): 149–54.

Kulkami, J. “Depression as a Side Effect of the Contraceptive Pill”. Expert Opinion on Drug Safety 6, no. 4 (2007): 371–74.

Lewis, M. A., et al. “Third Generation Oral Contraceptives and Risk of Myocardial Infarction: An International Case-Control Study. Transnational Research Group on Oral Contraceptives and the Health of Young Women”. British Medical Journal 312, no. 7023 (1996): 88–90.

Maes, M., et al. “The Effects of Glucocorticoids on the Availability of L-Tryptophan and Tyrosine in the Plasma of Depressed Patients”. Journal of Affective Disorders 18, no. 2 (1990): 121–27. Marchbanks, P. A., et al. “Oral Contraceptives and the Risk of Breast Cancer”. New England Journal of Medicine 346 (2002): 2025–32.

Montoya, E. R., et al. “How Oral Contraceptives Impact Social-Emotional Behavior and Brain Function”. Trends in Cognitive Sciences 21, no. 2 (2017): 125–36.

Myint, A. M., et al. “The Role of the Kynurenine Metabolism in Major Depression”. Journal of Neural Transmission 119, no. 2 (2012): 245–51.

Nassaralla, C. L., et al. “Characteristics of the Menstrual Cycle after Discontinuation of Oral Contraceptives”. Journal of Women’s Health 20, no. 2 (2011): 169–77.

Oinonen, K. A., et al. “To What Extent Do Oral Contraceptives Influence Mood and Affect?” Journal of Affective Disorders 70, no. 3 (2002): 229–40.

“Oral-Contraceptive Use and the Risk of Breast Cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development”. New England Journal of Medicine 315, no. 7 (1986): 405–11.

Palan, P. R., et al. “Effects of Oral, Vaginal, and Transdermal Hormonal Contraception on Serum Levels of Coenzyme Q10, Vitamin E, and Total Antioxidant Activity”. Obstetrics and Gynaecology International (2010), article ID 925635.

Palmery, M., et al. “Oral Contraceptives and Changes in Nutritional Requirements”. European Review for Medical and Pharmacological Sciences 17, no. 13 (2013): 1804–13.

Panzer, C., et al. “Impact of Oral Contraceptives on Sex Hormone – Binding Globulin and Androgen Levels: A Retrospective Study in Women with Sexual Dysfunction”. Journal of Sexual Medicine 3, no. 1 (2006): 104–13.

Park, B., et al. “Oral Contraceptive Use, Micronutrient Deficiency, and Obesity Among Premenopausal Females in Korea: The Necessity of Dietary Supplements and Food Intake Improvement”. PLoS One 11, no. 6 (2016): e0158177.

Peddie, B. A., et al. “Relationship Between Contraceptive Method and Vaginal Flora”. Australian and New Zealand Journal of Obstetrics and Gynaecology 24, no. 3 (1984): 217–18.

Piltonen, T., et al. “Oral, Transdermal, and Vaginal Combined Contraceptives Induce an Increase in Markers of Chronic Inflammation and Impair Insulin Sensitivity in Young Healthy Normal-Weight Women: A Randomized Study”. Human Reproduction 27, no. 10 (2012): 3046–56.

Rohr, U. D. “The Impact of Testosterone Imbalance on Depression and Women’s Health”. Maturitas 41, suppl. 1 (2002): S25–46.

Sarkar, M., et al. “Influence of Moonlight on the Birth of Male and Female Babies”. Nepal Medical College Journal 7, no. 1 (2005): 62–64.

Schatz, D. L., et al. “Effects of Oral Contraceptives and Pregnancy on Thyroid Function”. Canadian Medical Association Journal 99, no. 18 (1968): 882–86.

Schmidt, A., et al. “Oral Contraceptive Use and Vaginal Candida Colonization”. [In German.] Zentralbl Gynakol 119, no. 11 (1997): 545–49.

Shakerinejad, G., et al. “Factors Predicting Mood Changes in Oral Contraceptive Pill Users”. Reproductive Health 10 (2013): 45.

Skovlund, C. W., et al. “Association of Hormonal Contraception with Depression”. JAMA Psychiatry 73, no. 11 (2016): 1154–62.

Skovlund, C. W., et al. “Association of Hormonal Contraception with Suicide Attempts and Suicides”. American Journal of Psychiatry 175, no. 4 (2017): 336–42.

Smith, J. S., et al. “Cervical Cancer and Use of Hormonal Contraceptives: A Systematic Review”. Lancet 361, no. 9364 (2003): 1159–67.

Sorgdrager, F. J. H., et al. “The Association Between the Hypothalamic Pituitary Adrenal Axis and Tryptophan Metabolism in Persons with Recurrent Major Depressive Disorder and Healthy Controls”. Journal of Affective Disorders 222 (2017): 32–39.

Talukdar, N., et al. “Effect of Long-Term Combined Oral Contraceptive Pill Use on Endometrial Thickness”. Obstetrics and Gynecology 120, no. 2, pt. 1 (2012): 348–54.

Turna, B., et al. “Women with Low Libido: Correlation of Decreased Androgen Levels with Female Sexual Function Index”. International Journal of Impotence Research 17, no. 2 (2005): 148–53.

Van de Wijgert, J. H., et al. “Hormonal Contraception Decreases Bacterial Vaginosis but Oral Contraception May Increase Candidiasis: Implications for HIV Transmission”. AIDS 27, no. 13 (2013): 2141–53.

Van Hylckama Vlieg, A., et al. “The Venous Thrombotic Risk of Oral Contraceptives, Effects of Oestrogen Dose and Progestogen Type: Results of the MEGA Case-Control Study”. British Medical Journal 339 (2009): b2921.

Vessey, M., et al. “Oral Contraceptive Use and Cancer. Findings in a Large Cohort Study, 1968–2004”. British Journal of Cancer 95, no. 3 (2006): 385–89.

Wang, Q., et al. “Effects of Hormonal Contraception on Systemic Metabolism: Cross-Sectional and Longitudinal Evidence”. International Journal of Epidemiology 45, no. 5 (2016): 1445–57.

Webb, J. L. “Nutritional Effects of Oral Contraceptive Use: A Review”. Journal of Reproductive Medicine 25, no. 4 (1980): 150–56.

White, T., et al. “Effects of Transdermal and Oral Contraceptives on Estrogen-Sensitive Hepatic Proteins”. Contraception 74, no. 4 (2006): 293–96.

Wiegratz, I., et al. “Effect of Four Different Oral Contraceptives on Various Sex Hormones and Serum-Binding Globulins”. Contraception 67, no. 1 (2003): 25–32.

Zimmerman, Y., et al. “The Effect of Combined Oral Contraception on Testosterone Levels in Healthy Women: A Systematic Review and Meta-Analysis”. Human Reproduction Update 20, no. 1 (2014): 76–105.

Adams, J. M., et al. “The Midcycle Gonadotropin Surge in Normal Women Occurs in the Face of an Unchanging Gonadotropin-Releasing Hormone Pulse Frequency”. Journal of Clinical Endocrinology and Metabolism 79 (1994): 858–64.

Baerwald, A. R., O. A. Olatunbosun, and R. A. Pierson. “Ovarian Follicular Development Is Initiated During the Hormone-Free Interval of Oral Contraceptive Use”. Contraception 70, no. 5 (2004): 371–77.

Cella, F., G. Giordano, and R. Cordera. “Serum Leptin Concentrations During the Menstrual Cycle in Normal-Weight Women: Effects of an Oral Triphasic Estrogen-Progestin Medication”. European Journal of Endocrinology 142 (2000): 174–78.

Clubb, E. “Natural Methods of Family Planning”. Journal of the Royal Society of Health 106, no. 4 (1986): 121–26.

Crosignani, P. G., et al. “Ovarian Activity During Regular Oral Contraceptive Use”. Contraception 54, no. 5 (1996): 271–73.

Davis, A. R., et al. “Occurrence of Menses or Pregnancy After Cessation of a Continuous Oral Contraceptive”. Fertility and Sterility 89, no. 5 (2008): 1059–63.

Filicori, M., J. P. Butler, and W. F. Crowley Jr. “Neuroendocrine Regulation of the Corpus Luteum in the Human. Evidence for Pulsatile Progesterone Secretion”. Journal of Clinical Investigation 73 (1984): 1638–47.

Filicori, M., N. Santoro, G. R. Merriam, and W. F. Crowley Jr. “Characterization of the Physiological Pattern of Episodic Gonadotropin Secretion Throughout the Human Menstrual Cycle”. Journal of Clinical Endocrinology and Metabolism 62 (1986): 1136–44.

Fleischer, A. C., G. C. Kalemeris, and S. S. Entman. “Sonographic Depiction of the Endometrium During Normal Cycles”. Ultrasound in Medicine and Biology 12, no. 4 (1986): 271–77.

Gipson, I. K., et al. “The Amount of MUC5B Mucin in Cervical Mucus Peaks at Midcycle”. Journal of Clinical Endocrinology and Metabolism 86, no. 2 (2001): 594–600.

Gougeon, A. “Dynamics of Follicular Growth in the Human: A Model from Preliminary Results”. Human Reproduction 1, no. 2 (1986): 81–87.

Gougeon A. “Dynamics of Human Follicular Growth: A Morphologic Perspective”. In The Ovary, edited by E. Y. Adashi and P. C. K. Leung (New York: Raven Press, 1993), p. 21.

Hall, J. E., D. A. Schoenfeld, K. A. Martin, and W. F. Crowley Jr. “Hypothalamic Gonadotropin-Releasing Hormone Secretion and Follicle-Stimulating Hormone Dynamics During the Luteal-Follicular Transition”. Journal of Clinical Endocrinology and Metabolism 74, no. 3 (1992): 600–7.

Jacobs, H. S., et al. “Post-‘Pill’ Amenorrhoea – Cause or Coincidence?” British Medical Journal 2, no. 6092 (1977): 940–42.

Kenealy, B. P., et al. “Neuroestradiol in the Hypothalamus Contributes to the Regulation of Gonadotropin Releasing Hormone Release”. Journal of Neuroscience 33, no. 49 (2013): 19051–9.

Knochenhauer, E., and R. Azziz. “Ovarian Hormones and Adrenal Androgens During a Woman’s Life Span”. Journal of the American Academy of Dermatology 45, suppl. 3 (2001): S105–15.

Milsom, I., and T. Korver. “Ovulation Incidence with Oral Contraceptives: A Literature Review”. BMJ Sexual and Reproductive Health 34, no. 4 (2008): 237–46.

Morrison, A. I. “Persistence of Spermatozoa in the Vagina and Cervix”. British Journal of Venereal Diseases 48, no. 2 (1972): 141–43.

Richards, J. S. “Hormonal Control of Gene Expression in the Ovary”. Endocrine Reviews 15, no. 6 (1994): 725–51.

Rosenberg, M. J., and M. S. Waugh. “Oral Contraceptive Discontinuation: A Prospective Evaluation of Frequency and Reasons”. American Journal of Obstetrics and Gynecology 179, no. 3 (1998): 577–82.

Sherman, B. M., and S. G. Korenman. “Hormonal Characteristics of the Human Menstrual Cycle Throughout Reproductive Life”. Journal of Clinical Investigation 55, no. 4 (1975): 699–706.

Simpson, E. R. “Sources of Estrogen and Their Importance”. Journal of Steroid Biochemistry and Molecular Biology 86, no. 3–5 (2003): 225–30.

Stocco, C., C. Telleria, and G. Gibori. «The Molecular Control of Corpus Luteum Formation, Function, and Regression”. Endocrine Reviews 28 (2007): 117–49.

Suarez, S. S., and A. A. Pacey. “Sperm Transport in the Female Reproductive Tract”. Human Reproduction Update 12, no. 1 (2006): 23–37.

Taylor, A. E., et al. “Midcycle Levels of Sex Steroids Are Sufficient to Recreate the Follicle-Stimulating Hormone but Not the Luteinizing Hormone Midcycle Surge: Evidence for the Contribution of Other Ovarian Factors to the Surge in Normal Women”. Journal of Clinical Endocrinology and Metabolism 80, no. 5 (1995): 1541–47.

Treloar, A. E., R. E. Boynton, B. G. Behn, and B. W. Brown. “Variation of the Human Menstrual Cycle Trough Reproductive Life”. International Journal of Fertility 12, no. 1, pt. 2 (1967): 77–126.

Tsafriri, A., S. Y. Chun, and R. Reich. “Follicular Rupture and Ovulation”. In The Ovary, edited by E. Y. Adashi and P. C. K. Leung (New York: Raven Press, 1993), p. 227.

Welt, C. K., et al. “Frequency Modulation of Follicle-Stimulating Hormone (FSH) During the Luteal-Follicular Transition: Evidence for FSH Control of Inhibin B in Normal Women”. Journal of Clinical Endocrinology and Metabolism 82, no. 8 (1997): 2645–52.

Behre, H. M., et al. “Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men”. Journal of Clinical Endocrinology and Metabolism 101, no. 12 (2016): 4779–88.

Boyle, N. B., et al. “The Effects of Magnesium Supplementation on Subjective Anxiety and Stress – A Systematic Review”. Nutrients 9, no. 5 (2017): 429.

Cormia, F. E. “Alopecia from Oral Contraceptives”. JAMA 201, no. 8 (1967): 635–37.

Darney, P. D. “OC Practice Guidelines: Minimizing Side Effects”. International Journal of Fertility and Women’s Medicine, Supplement 1 (1997): 158–69.

Gebel Berg, E. “The Chemistry of the Pill”. ACS Central Science 1, no. 1 (2015): 5–7.

Gnoth, C., et al. “Cycle Characteristics After Discontinuation of Oral Contraceptives”. Gynecological Endocrinology 16, no. 4 (2002): 307–17.

Grifths, W. A. D. “Diffuse Hair Loss and Oral Contraceptives”. British Journal of Dermatology 88, no. 1 (1973): 31–36.

Grber, U., et al. “Magnesium in Prevention and Therapy”. Nutrients 7, no. 9 (2015): 8199–226.

Hammond, N., et al. “Nutritional Neuropathies”. Neurologic Clinics 31, no. 2 (2013): 477–89.

Johnson, S. “The Multifaceted and Widespread Pathology of Magnesium Deficiency”. Medical Hypotheses 56, no. 2 (2001): 163–70.

Kia, A. S., et al. “The Association Between the Risk of Premenstrual Syndrome and Vitamin D, Calcium, and Magnesium Status Among University Students: A Case Control Study”. Health Promotion Perspectives 5, no. 3 (2015): 225–30.

Lawrence, J. “NSAID Use May Prevent Fertile Women from Ovulating”. Pharmaceutical Journal 294, no. 7868/9 (2015).

McDowell, L. R. Vitamins in Animal and Human Nutrition. 2nd ed. Ames: Iowa State University Press, 2000, 265–310.

McIntosh, E. N. “Treatment of Women with the Galactorrhea-Amenorrhea Syndrome with Pyridoxine (Vitamin B6)”. Journal of Clinical Endocrinology and Metabolism 42, no. 6 (1976): 1192–95.

Mehta, K., et al. “Antiproliferative Effect of Curcumin (Diferuloylmethane) Against Human Breast Tumor Cell Line”. Anticancer Drugs 8, no. 5 (1997): 470–81.

Mendona, L. L. F., et al. “Non-Steroidal AntiInflammatory Drugs as a Possible Cause for Reversible Infertility”. Rheumatology 39, no. 8 (2000): 880–82.

Nabel, Elizabeth, G. “Coronary Heart Disease in Women – an Ounce of Prevention”. New England Journal of Medicine 343 (August 24, 2000): 572–74.

Parry, B. L., et al. “Oral Contraceptives and Depressive Symptomatology: Biologic Mechanisms”. Comprehensive Psychiatry 20, no. 4 (1979): 347–58.

Piltonen, T., et al. “Oral, Transdermal, and Vaginal Combined Contraceptives Induce an Increase in Markers of Chronic Inflammation and Impair Insulin Sensitivity in Young Healthy Normal-Weight Women: A Randomized Study”. Human Reproduction 27, no. 10 (2012): 3046–56.

Posaci, C., et al. “Plasma Copper, Zinc, and Magnesium Levels in Patients with Premenstrual Tension Syndrome”. Acta Obstetricia et Gynecologica Scandinavica 73, no. 6 (1994): 452–55.

Practice Committee of American Society for Reproductive Medicine. “Current Evaluation of Amenorrhea”. Fertility and Sterility 90, suppl. 5 (2008): S219–25.

Rajizadeh, A., et al. “Effect of Magnesium Supplementation on Depression Status in Depressed Patients with Magnesium Deficiency: A Randomized, Double-Blind, Placebo-Controlled Trial”. Nutrition 35 (2017): 56–60.

Ramos, P. M., et al. “Female Pattern Hair Loss: A Clinical and Pathophysiological Review”. Anais Brasileiros de Dermatologia 90, no. 4 (2015): 529–43.

Roberts, S. C., et al. “MHC–Correlated Odour Preferences in Humans and the Use of Oral Contraceptives”. Proceedings of the Royal Society B: Biological Sciences 275, no. 1652 (2008): 2715–22.

Rojas-Walsson, R., et al. “Diagnosis and Management of Post-Pill Amenorrhea”. Journal of Family Practice 13, no. 2 (1981): 165–69.

Stewart, M. E., et al. “Effect of Cyproterone Acetate-Ethinyl Estradiol Treatment on the Proportions of Linoleic and Sebaleic Acids in Various Skin Surface Lipid Classes”. Archives of Dermatological Research 278, no. 6 (1986): 481–85.

University of Pennsylvania School of Medicine. “Two Thirds of Women Interested in Stopping Their Periods but Unsure About Safety”. ScienceDaily. October 4, 2007.

Wang, J. G., et al. “The Complex Relationship Between Hypothalamic Amenorrhea and Polycystic Ovary Syndrome”. Journal of Clinical Endocrinology and Metabolism 93, no. 4 (2008): 1394–97.

Wedekind, C., et al. “Body OdourPreferences in Men and Women: Do They Aim for Specific MHC Combinations or Simply Heterozygosity?” Proceedings of the Royal Society B: Biological Sciences 264, no. 1387 (1997): 1471–79.

Wyatt, K. M., et al. “Efficacy of Vitamin B-6 in the Treatment of Premenstrual Syndrome: Systematic Review”. British Medical Journal 318, no. 7195 (1999): 1375–81.

American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. “Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign”. Committee Opinion No. 651. December 2015. https://www.acog.org/-/media/Committee – Opinions/Committee-on-Adolescent-Health-Care/co651.pdf?dmc=1&ts=20180626 T0442019822.

Bouchard, C., et al. “Use of Oral Contraceptive Pills and Vulvar Vestibulitis: A Case-Control Study”. American Journal of Epidemiology 156, no. 3 (2002): 254–61.

Goldstein, A. T., et al. “Polymorphisms of the Androgen Receptor Gene and Hormonal Contraceptive Induced Provoked Vestibulodynia”. Journal of Sexual Medicine 11, no. 11 (2014): 2764–71.

Baum, J. K., et al. “Possible Association Between Benign Hepatomas and Oral Contraceptives”. Lancet 2, no. 7835 (1973): 926–29.

Blackwell. “Oral Contraceptive Pill May Prevent More than Pregnancy: Could Cause Long-Term Problems with Testosterone”. ScienceDaily.com. January 5, 2006.

https:// www.sciencedaily.com/releases/2006/01/060104232338.htm.

Bradlow, H. L., et al. “Multifunctional Aspects of the Action of Indole-3-Carbinol as an Antitumor Agent”. Annals of the New York Academy of Sciences 889 (1999): 204–13.

Bradlow, H. L., et al. “2-Hydroxyestrone: The ‘Good’ Estrogen”. Journal of Endocrinology 150 suppl. (1996): S259–65.

Dawling, S., et al. “Catechol-o-methyltransferase (COMT)-Mediated Metabolism of Catechol Estrogens: Comparison of Wild-Type and Variant COMT Isoforms”. Cancer Research 61, no. 18 (2001): 6716–22.

De Waal, E. J., et al. “Differential Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin, Bis(tri-n butyltin) Oxide, and Cyclosporine on Thymus Histophysiology”. Critical Reviews in Toxicology 27, no. 4 (1997): 381–430.

Edmondson, H. A., et al. “Liver-Cell Adenomas Associated with Use of Oral Contraceptives”. New England Journal of Medicine 294, no. 9 (1976): 470–72.

Eramo, S., et al. “Estrogenicity of Bisphenol A Released from Sealants and Composites: A Review of the Literature”. Annali di Stomatologia 1, nos. 3–4 (2010): 14–21.

Etminan, M., et al. “Oral Contraceptives and the Risk of Gallbladder Disease: A Comparative Safety Study”. Canadian Medical Association Journal 183, no. 8 (2011): 899–904.

Fishman, W. H. “Beta-Glucuronidase in the Metabolic Conjugation of Estrogenic Hormones”. Federation Proceedings 6, no. 1, pt. 2 (1947): 251.

Fowke, J. H., et al. “Brassica Vegetable Consumption Shifts Estrogen Metabolism in Healthy Postmenopausal Women”. Cancer Epidemiology, Biomarkers and Prevention 9, no. 8 (2000): 773–79.

Hofmann, A. F. “The Continuing Importance of Bile Acids in Liver and Intestinal Disease”. Archives of Internal Medicine 159, no. 22 (1999): 2647–58.

Klatskin, G. “Hepatic Tumors: Possible Relationship to Use of Oral Contraceptives”. Gastroenterology 73, no. 2 (1977): 386–94.

Kuhl, H., et al. “The Effect of Sex Steroids and Hormonal Contraceptives upon Thymus and Spleen on Intact Female Rats”. Contraception 28, no. 6 (1983): 587–601.

Lord, R. S., et al. “Estrogen Metabolism and the Diet-Cancer Connection: Rationale for Assessing the Ratio of Urinary Hydroxylated Estrogen Metabolites”. Alternative Medicine Review 7, no. 2 (2002): 112–29.

Marciani, L., et al. “Effects of Various Food Ingredients on Gallbladder Emptying”. European Journal of Clinical Nutrition 67, no. 11 (2013): 1182–87.

McCann, S. E., et al. “Changes in 2-Hydroxyestrone and 16-Hydroxyestrone Metabolism with Flaxseed Consumption: Modification by COMT and CYP1B1 Genotype”. Cancer Epidemiology, Biomarkers and Prevention 16, no. 2 (2007): 256–62.

Meissner, K. “Hemorrhage Caused by Ruptured Liver Cell Adenoma Following Long-Term Oral Contraceptives: A Case Report”. Hepatogastroenterology 45, no. 19 (1998): 224–25. Mueck, A. O., et al. “Estradiol Metabolism and Malignant Disease”. Maturitas 43, no. 1 (2002): 1–10.

Muti, P., et al. “Estrogen Metabolism and Risk of Breast Cancer: A Prospective Study of the 2:16Alpha-Hydroxyestrone Ratio in Premenopausal and Postmenopausal Women”. Epidemiology 11, no. 6 (2000): 635–40.

Nime, F., et al. “The Histology of Liver Tumors in Oral Contraceptive Users Observed During a National Survey by the American College of Surgeons Commission on Cancer”. Cancer 44, no. 4 (1979): 1481–89.

Nwachukwu, J. C., et al. “Resveratrol Modulates the Inflammatory Response Via an Estrogen Receptor-Signal Integration Network”. Elife 3 (2014): e02057.

Oredipe, O. A., et al. “Dietary Glucarate-Mediated Inhibition of Initiation of Diethyl-nitrosamine-Induced Hepatocarcinogenesis”. Toxicology 74, nos. 2–3 (1992): 209–22.

Panzer, C., et al. “Impact of Oral Contraceptives on Sex Hormone – Binding Globulin and Androgen Levels: A Retrospective Study in Women with Sexual Dysfunction”. Journal of Sexual Medicine 3, no. 1: 104–13.

Prigge, J. R., et al. “Hepatocyte DNA Replication in Growing Liver Requires Either Glutathione or a Single Allele of TXNRD1”. Free Radical Biology and Medicine 52, no. 4 (2012): 803–10.

Racine, A., et al. “Menopausal Hormone Therapy and Risk of Cholecystectomy: A Prospective Study Based on the French E3N Cohort”. Canadian Medical Association Journal 185, no. 7 (2013): 555–61.

Rafogianis, R., et al. “Estrogen Metabolism by Conjugation”. Journal of the National Cancer Institute Monographs 27 (2000): 113–24.

Rooks, J. B., et al. “Epidemiology of Hepatocellular Adenoma. The Role of Oral Contraceptive Use”. JAMA 242, no. 7 (1979): 644–48.

Rosenberg, L. “The Risk of Liver Neoplasia in Relation to Combined Oral Contraceptive Use”. Contraception 43, no. 6 (1991): 643–52.

Ruotolo, R., et al. “Anti-Estrogenic Activity of a Human Resveratrol Metabolite”. Nutrition, Metabolism, and Cardiovascular Diseases 23, no. 11 (2013): 1086–92.

Schuurman, H. J., et al. “Chemicals Trophic for the Thymus: Risk for Immunodeficiency and Autoimmunity”. International Journal of Immunopharmacology 14, no. 3 (1992): 369–75.

Shortell, C. K., et al. “Hepatic Adenoma and Focal Nodular Hyperplasia”. Surgery, Gynecology, and Obstetrics 173, no. 5 (1991): 426–31.

Se, K. L., et al. “Liver Pathology Associated with the Use of Anabolic-Androgenic Steroids”. Liver 12, no. 2 (1992): 73–79.

Steiner, J. L., et al. “Dose-Dependent Benefits of Quercetin on Tumorigenesis in the C3(1)/ SV40Tag Transgenic Mouse Model of Breast Cancer”. Cancer Biology and Therapy 15, no. 11 (2014): 1456–67.

Ursin, G., et al. “Urinary 2-Hydroxyestrone/16Alpha-Hydroxyestrone Ratio and Risk of Breast Cancer in Postmenopausal Women”. Journal of the National Cancer Institute 91, no. 12 (1999): 1067–72.

Wallwiener, C. W., et al. “Prevalence of Sexual Dysfunction and Impact of Contraception in Female German Medical Students”. Journal of Sexual Medicine 7, no. 6 (2010): 2139–48.

Wu, Z., et al. “Progesterone Inhibits L-Type Calcium Currents in Gall Bladder Smooth Muscle Cells”. Journal of Gastroenterology and Hepatology 25, no. 12 (2010): 1838–43.

Yang, C. Z., et al. “Most Plastic Products Release Estrogenic Chemicals: A Potential Health Problem Tat Can Be Solved”. Environmental Health Perspectives 119, no. 7 (2011): 989–96.

Zhang, L. Q., et al. “Potential Therapeutic Targets for the Primary Gallbladder Carcinoma: Estrogen Receptors”. Asian Pacific Journal of Cancer Prevention 14, no. 4 (2013): 2185–90.

Adlercretz, H., et al. “Studies on the Role of Intestinal Bacteria in Metabolism of Synthetic and Natural Steroid Hormones”. Journal of Steroid Biochemistry 20, no. 1 (1984): 217–29.

Ashraf, M., et al. “The Presence of Anti-Thyroid and Anti-Ovarian Auto-Antibodies in Familial Premature Ovarian Failure”. International Journal of Fertility and Sterility 1, no. 4 (2008): 171–74.

Bast, A., et al. “Celiac Disease and Reproductive Health”. Practical Gastroenterology 35, no. 10 (2009): 10–21.

Bernier, M. O., et al. “Combined Oral Contraceptive Use and the Risk of Systemic Lupus Erythematosus”. Arthritis and Rheumatology 61, no. 4 (2009): 476–81.

Blasi, F., et al. “The Effect of N-Acetylcysteine on Biofilms: Implications for the Treatment of Respiratory Tract Infections”. Respiratory Medicine 117 (2016): 190–97.

Bultman, S. J. “The Microbiome and Its Potential as a Cancer Preventive Intervention”. Seminars in Oncology 43, no. 1 (2016): 97–106.

Campana, R., et al. “Strain-Specific Probiotic Properties of Lactic Acid Bacteria and Their Interference with Human Intestinal Pathogens Invasion”. Gut Pathogens 9, no. 1 (2017): 12.

Cook, L. C., et al. “The Role of Estrogen Signaling in a Mouse Model of Inflammatory Bowel Disease: A Helicobacter Hepaticus Model”. PLoS One 9, no. 4 (2014): e94209.

Costenbader, K. H., et al. “Reproductive and Menopausal Factors and Risk of Systemic Lupus Erythematosus in Women”. Arthritis and Rheumatology 56, no. 4 (2007): 1251–62.

Crujeiras, A. B., et al. “Leptin Resistance in Obesity: An Epigenetic Landscape”. Life Sciences 140 (2015): 57–63.

Cummings, S. R., et al. “Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk”. Journal of the National Cancer Institute 101, no. 6 (2009): 384–98.

Cutolo, M., et al. “Estrogens and Autoimmune Diseases”. Annals of the New York Academy of Sciences 1089 (2006): 538–47.

Dai, Z. L., et al. “L-Glutamine Regulates Amino Acid Utilization by Intestinal Bacteria”. Amino Acids 45, no. 3 (2013): 501–12.

De Kort, S., et al. “Leaky Gut and Diabetes Mellitus: What Is the Link?” Obesity Reviews 12, no. 6 (2011): 449–58.

Dinicola, S., et al. “N-Acetylcysteine as Powerful Molecule to Destroy Bacterial Biofilms. A Systematic Review”. European Review for Medical and Pharmacological Sciences 18, no. 19 (2014): 2942–48.

Divi, R. L., et al. “Anti-thyroid Isoflavones from Soybean: Isolation, Characterization, and Mechanisms of Action”. Biochemical Pharmacology 54, no. 10 (1997): 1087–96.

Engen, P. A., et al. “The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota”. Alcohol Research 37, no. 2 (2015): 223–36.

Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. “Contraceptive Choices for Women with Inflammatory Bowel Disease”. Journal of Family Planning and Reproductive Health Care 29, no. 3 (2003): 127–35. http://srh.bmj.com /content/familyplanning/29/3/127.full.pdf.

Fasano, A. “Leaky Gut and Autoimmune Diseases”. Clinical Reviews in Allergy and Immunology 42, no. 1 (2012): 71–78.

Fasano, A. “Zonulin, Regulation of Tight Junctions, and Autoimmune Diseases”. Annals of the New York Academy of Sciences 1258 (2012): 25–33.

Fasano, A., et al. “Mechanisms of Disease: The Role of Intestinal Barrier Function in the Pathogenesis of Gastrointestinal Autoimmune Diseases”. Nature Clinical Practice. Gastroenterology and Hepatology 2, no. 9 (2005): 416–22.

Fnichel, P., et al. “Prevalence, Specificity, and Significance of Ovarian Antibodies During Spontaneous Premature Ovarian Failure”. Human Reproduction 12, no. 12 (1997): 2623–28.